Biotechnology - San Antonio, Texas, United States
Aperion Biologics has developed and patented a technique to make animal tissues usable for human applications without causing rejection. The core platform technology is an enzymatic stripping of the key carbohydrate antigens followed by a unique conversion process that both "humanizes" and sterilizes the tissues without affecting their biomechanical or biological properties. This tissue scaffold provides mechanical stability and function while being biologically integrated and remodeled. Aperion's Z-Process™ of humanizing and sterilizing tissue can be applied to a variety of tissues from orthopaedic ligaments, bone, and meniscus to cardiovascular valves and vessels to soft tissue grafts for augmentation and repair.
Mobile Friendly